Nurse Practitioner · Endwell, NY
NPI
1326691734
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
333 Hooper Rd
Endwell, NY, 13760
Phone (607) 729-2777
Groups this clinician bills Medicare through
Medicare paid, 2024
$116K
3,555 services
Medicare patients, 2024
848
Average age 74
Drug cost, 2024
$1.2M
1,333 prescriptions
Company payments, 2025
$694
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heather Fisher was code 17003 (destruction skin lesion), 1,275 times for 241 patients. In total Heather Fisher billed 3,555 services in 44 codes, and Medicare paid $116K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,275 | 241 | $3.84 | $4,894 |
| 99213 Office E&M - Established | Office | 894 | 658 | $48.24 | $43K |
| 17000 Destruction Skin Lesion | Office | 441 | 345 | $28.98 | $13K |
| 17110 Destruction Skin Lesion | Office | 286 | 246 | $61.64 | $18K |
| 99203 Office E&M - New | Office | 142 | 142 | $51.64 | $7,333 |
| 11102 Skin Biopsy | Office | 139 | 133 | $47.31 | $6,576 |
| 99214 Office E&M - Established | Office | 94 | 69 | $67.08 | $6,306 |
| 17111 Destruction Skin Lesion | Office | 33 | 29 | $71.08 | $2,345 |
| 17004 Destruction Skin Lesion | Office | 30 | 25 | $103.19 | $3,096 |
| 11103 Skin Biopsy | Office | 28 | 19 | $30.13 | $844 |
| 99212 Office E&M - Established | Office | 24 | 22 | $30.58 | $734 |
| 11301 Removal or Shaving of Skin Growth | Office | 19 | 16 | $56.74 | $1,078 |
| 11302 Removal or Shaving of Skin Growth | Office | 17 | 15 | $65.72 | $1,117 |
| 10060 Skin | Office | 16 | 16 | $68.42 | $1,095 |
| 11311 Removal or Shaving of Skin Growth | Office | 13 | 12 | $62.72 | $815 |
By year: 2022 $135K for 4,010 services; 2023 $114K for 3,411 services; 2024 $116K for 3,555 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heather Fisher prescribed most often to Medicare patients was Triamcinolone Acetonide, with 202 prescriptions and refills. In total Heather Fisher wrote 1,333 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 202 | 229 | 137 | $2,414 |
| Clobetasol Propionate Generic | 201 | 211 | 133 | $8,322 |
| Ketoconazole Generic | 154 | 177 | 83 | $3,043 |
| Doxycycline Hyclate Generic | 132 | 180 | 42 | $2,396 |
| Prednisone Generic | 90 | 92 | 69 | $237 |
| Metronidazole Generic | 36 | 50 | 25 | $2,146 |
| Imiquimod Generic | 36 | 37 | 33 | $1,282 |
| Clindamycin Phosphate Generic | 36 | 39 | 21 | $1,172 |
| Dupixent Pen Dupilumab | 27 | 27 | Under 11 | $99K |
| Tremfya Guselkumab | 27 | 50 | Under 11 | $357K |
| Fluorouracil Generic | 26 | 28 | 25 | $1,719 |
| Hydroxyzine Hcl Generic | 19 | 29 | Under 11 | $121 |
| Azelaic Acid Generic | 19 | 28 | 16 | $2,131 |
| Valacyclovir Valacyclovir Hcl | 17 | 24 | Under 11 | $530 |
| Terbinafine Hcl Generic | 17 | 22 | 13 | $102 |
Brand drugs: - claims; generic drugs: 1,190 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heather Fisher $694 ($694 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $234.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $234 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $195 |
| Genzyme Corporation SNY | 4 | $71.92 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $41.29 |
| Pfizer Inc. PFE | 2 | $41.11 |
| UCB, Inc. UCB.BR | 1 | $38.06 |
| Lilly USA, LLC LLY | 1 | $23.8 |
| Amgen Inc. AMGN | 1 | $20.88 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $15.2 |
| Organon LLC OGN | 4 | $12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.